Badalamenti, PharmD VC, Buckley, PharmD JW, Smith, PharmD ET. Safety of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules: Review of postmarketing adverse events during the first year. J of Opioid Management [Internet]. 2012 Mar. 1 [cited 2024 Nov. 22];8(2):115-2. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/780